The largest database of trusted experimental protocols

5 protocols using p38 inhibitor 4

1

Replication Assays and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
For replication assays, cells were seeded in 24-well plates at 1 × 105 cells/well and for western blotting in 60 mm dishes at 2 × 105 cells/dish. Plates were then treated with one of the following inhibitors; salirasib [10 μM] (Sigma), p38 inhibitor IV [10 μM] (Sigma) or PD 184352 [1 μM] (Selleck), 1 hour before irradiation at 5 Gy. Cells were infected with RT3D (MOI 5) 4 hours after irradiation. One-step growth curves and western blotting were carried out as described.
+ Open protocol
+ Expand
2

Induced iTreg Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted naive CD4+CD62L+Foxp3EGFP− T cells (1 × 106/ml) were cultured with plate-bound anti-CD28 (5 μg/ml, Biolegend), anti-CD3 (5 μg/ml, Biolegend), recombinant TGF β1 (5 ng/ml, R&D Systems), with or without murine recombinant IL-4 (10 ng/ml) (Perpotech), anti-IL-4 (11B11, 10 μg/ml) (Biolegend) or anti-IL-6 mAb (MP5-20F3, 10 μg/ml) (Biolegend), mitogen activated protein kinase kinase (MEK) inhibitor PD98059 (50 μM, Sigma-Aldrich) or P38 inhibitor IV (10 μM, Sigma-Aldrich). After 4 days, the induced iTreg cells were analyzed by flow cytometry for Foxp3 expression and intracellular cytokines production and/or re-sorted on the basis of EGFP fluorescence.
+ Open protocol
+ Expand
3

Induction and Characterization of Induced T-regulatory Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted naïve CD4+CD62L+Foxp3YFPCre T cells (1 × 106/ml) were cultured with plate-bound anti-CD28 (5 μg/ml, Biolegend), anti-CD3 (clone: 145–2C11, 5 μg/ml, Biolegend), recombinant TGF-β1 (5 ng/ml, R&D Systems), with or without IL-4 (10 ng/ml) (Peprotech), anti-IL-4 (clone: 11B11, 10 μg/ml) (Biolegend) or anti-IL-6 mAb (MP5–20F3, 10 μg/ml) (Biolegend), mitogen activated protein kinase (MEK) inhibitor PD98059 (50 μM, Sigma-Aldrich) or P38 inhibitor IV (10 μM, Sigma-Aldrich). After 4 days, the induced Treg cells were analyzed by flow cytometry for Foxp3 expression and intracellular cytokines production and/ re-sorted on the basis of YFP expression.
+ Open protocol
+ Expand
4

Induction and Characterization of Induced T-regulatory Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted naïve CD4+CD62L+Foxp3YFPCre T cells (1 × 106/ml) were cultured with plate-bound anti-CD28 (5 μg/ml, Biolegend), anti-CD3 (clone: 145–2C11, 5 μg/ml, Biolegend), recombinant TGF-β1 (5 ng/ml, R&D Systems), with or without IL-4 (10 ng/ml) (Peprotech), anti-IL-4 (clone: 11B11, 10 μg/ml) (Biolegend) or anti-IL-6 mAb (MP5–20F3, 10 μg/ml) (Biolegend), mitogen activated protein kinase (MEK) inhibitor PD98059 (50 μM, Sigma-Aldrich) or P38 inhibitor IV (10 μM, Sigma-Aldrich). After 4 days, the induced Treg cells were analyzed by flow cytometry for Foxp3 expression and intracellular cytokines production and/ re-sorted on the basis of YFP expression.
+ Open protocol
+ Expand
5

Induced iTreg Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted naive CD4+CD62L+Foxp3EGFP− T cells (1 × 106/ml) were cultured with plate-bound anti-CD28 (5 μg/ml, Biolegend), anti-CD3 (5 μg/ml, Biolegend), recombinant TGF β1 (5 ng/ml, R&D Systems), with or without murine recombinant IL-4 (10 ng/ml) (Perpotech), anti-IL-4 (11B11, 10 μg/ml) (Biolegend) or anti-IL-6 mAb (MP5-20F3, 10 μg/ml) (Biolegend), mitogen activated protein kinase kinase (MEK) inhibitor PD98059 (50 μM, Sigma-Aldrich) or P38 inhibitor IV (10 μM, Sigma-Aldrich). After 4 days, the induced iTreg cells were analyzed by flow cytometry for Foxp3 expression and intracellular cytokines production and/or re-sorted on the basis of EGFP fluorescence.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!